|
|
||||||||




*
Immunobiology Vaccine Center and Departments of Oral Biology and Microbiology, University of Alabama, Birmingham, AL 35294;
Department of Microbiology, National Institute of Public Health, Minato, Tokyo, Japan;
California Regional Primate Research Center, University of California, Davis, CA 95615;
§
AIDS Research Center, National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan; and
¶
Department of Mucosal Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan
Female rhesus macaques were nasally immunized with
p55gag (p55) of SIV and cholera toxin as
a mucosal adjuvant. Nasal immunization induced Ag-specific IgA and IgG
Abs in mucosal secretions (e.g., cervicovaginal secretions, rectal
washes, and saliva) and serum. Furthermore, high numbers of
p55-specific IgA and IgG Ab-forming cells were induced in mucosal
effector sites, i.e., uterine cervix, intestinal lamina propria, and
nasal passage. p55-specific CD4+ T cells in both systemic
and mucosal compartments expressed IFN-
and IL-2 (Th1-type)- as well
as IL-5, IL-6, and IL-10 (Th2-type)-specific mRNA. Moreover,
p55-specific CTL activity was demonstrated in lymphocytes from blood,
tonsils, and other lymphoid tissues. These results show that nasal
immunization with SIV p55 with cholera toxin elicits both Th1- and
selective Th2-type cytokine responses associated with the induction of
SIV-specific mucosal and serum Abs, and CTL activity. These results
offer a promise for the development of protective mucosal immunity to
SIV.
This article has been cited by other articles:
![]() |
D. Medaglini, A. Ciabattini, A. M. Cuppone, C. Costa, S. Ricci, M. Costalonga, and G. Pozzi In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii. Infect. Immun., May 1, 2006; 74(5): 2760 - 2766. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, R. Janani, Q. Bin, P. Luciw, C. Greer, S. Perri, H. Legg, J. Donnelly, S. Barnett, D. O'Hagan, et al. Characterization of Human Immunodeficiency Virus Gag-Specific Gamma Interferon-Expressing Cells following Protective Mucosal Immunization with Alphavirus Replicon Particles J. Virol., June 1, 2005; 79(11): 7135 - 7145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kobayashi, T. Kohda, K. Kataoka, H. Ihara, S. Kozaki, D. W. Pascual, H. F. Staats, H. Kiyono, J. R. McGhee, and K. Fujihashi A Novel Neurotoxoid Vaccine Prevents Mucosal Botulism J. Immunol., February 15, 2005; 174(4): 2190 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Yoshino, F. X.-S. Lu, K. Fujihashi, Y. Hagiwara, K. Kataoka, D. Lu, L. Hirst, M. Honda, F. W. van Ginkel, Y. Takeda, et al. A Novel Adjuvant for Mucosal Immunity to HIV-1 gp120 in Nonhuman Primates J. Immunol., December 1, 2004; 173(11): 6850 - 6857. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Abel, L. Compton, T. Rourke, D. Montefiori, D. Lu, K. Rothaeusler, L. Fritts, K. Bost, and C. J. Miller Simian-Human Immunodeficiency Virus SHIV89.6-Induced Protection against Intravaginal Challenge with Pathogenic SIVmac239 Is Independent of the Route of Immunization and Is Associated with a Combination of Cytotoxic T-Lymphocyte and Alpha Interferon Responses J. Virol., March 1, 2003; 77(5): 3099 - 3118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sakaue, T. Hiroi, Y. Nakagawa, K. Someya, K. Iwatani, Y. Sawa, H. Takahashi, M. Honda, J. Kunisawa, and H. Kiyono HIV Mucosal Vaccine: Nasal Immunization with gp160-Encapsulated Hemagglutinating Virus of Japan-Liposome Induces Antigen-Specific CTLs and Neutralizing Antibody Responses J. Immunol., January 1, 2003; 170(1): 495 - 502. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Bradney, G. D. Sempowski, H.-X. Liao, B. F. Haynes, and H. F. Staats Cytokines as Adjuvants for the Induction of Anti-Human Immunodeficiency Virus Peptide Immunoglobulin G (IgG) and IgA Antibodies in Serum and Mucosal Secretions after Nasal Immunization J. Virol., January 15, 2002; 76(2): 517 - 524. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stevceva, B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini Cervicovaginal Lamina Propria Lymphocytes: Phenotypic Characterization and Their Importance in Cytotoxic T-Lymphocyte Responses to Simian Immunodeficiency Virus SIVmac251 J. Virol., January 1, 2002; 76(1): 9 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fromantin, B. Jamot, J. Cohen, L. Piroth, P. Pothier, and E. Kohli Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response J. Virol., November 15, 2001; 75(22): 11010 - 11016. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ada Vaccines and Vaccination N. Engl. J. Med., October 4, 2001; 345(14): 1042 - 1053. [Full Text] [PDF] |
||||
![]() |
S. Crotty, C. J. Miller, B. L. Lohman, M. R. Neagu, L. Compton, D. Lu, F. X.-S. Lu, L. Fritts, J. D. Lifson, and R. Andino Protection against Simian Immunodeficiency Virus Vaginal Challenge by Using Sabin Poliovirus Vectors J. Virol., August 15, 2001; 75(16): 7435 - 7452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Wang, P. A. Kozlowski, G. Schmelz, K. Manson, M. S. Wyand, R. Glickman, D. Montefiori, J. D. Lifson, R. P. Johnson, M. R. Neutra, et al. Effective Induction of Simian Immunodeficiency Virus-Specific Systemic and Mucosal Immune Responses in Primates by Vaccination with Proviral DNA Producing Intact but Noninfectious Virions J. Virol., November 15, 2000; 74(22): 10514 - 10522. [Abstract] [Full Text] |
||||
![]() |
S. Crotty, B. L. Lohman, F. X.-S. Lu, S. Tang, C. J. Miller, and R. Andino Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity J. Virol., November 1, 1999; 73(11): 9485 - 9495. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |